GENE ONLINE|News &
Opinion
Blog

ALS
Asia-Pacific ALS
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27Partner
Trials & Approvals ALS
FDA Rejects BrainStorm Cell Therapeutics’ BLA For ALS Drug
2022-11-11
Trials & Approvals Biogen
FDA Pushes Biogen’s ALS Drug Approval Date Back Three Months
2022-10-18
Trials & Approvals ALS
Amylyx’s ALS Drug Nabs FDA Nod After Rare Regulatory Reversal
2022-09-29
Technology ALS
Insilico Medicine Pinpoints New Targets for ALS With AI
2022-07-08
Trials & Approvals ALS
Canada Approves Amylyx’s Experimental ALS Drug
2022-06-14
Trials & Approvals ALS
Amylyx’s New ALS Drug Review Impeded as FDA Members Disagreed with Clinical Trial Results
2022-04-04
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top